Latest
Recommended
Published: Mon, February 20, 2017
World | By Tasha Manning

Zambon Group SPA

Zambon Group SPA

Zambon is a leading Italian pharmaceutical and fine-chemical multinational company, which has gained strong reputation over the years for high quality products and services. Zambon is well-established in 3 therapeutic areas: respiratory, pain and woman care, and is very strongly committed to its entry into the CNS space. Zambon SpA produces high quality products thanks to the management of the whole production chain which involves Zach (Zambon chemical), a privileged partner for API, custom synthesis and generic products.

Low amniotic fluid: How is it treated? - Mayo Clinic
In addition, the amount of amniotic fluid reflects the baby's urine output - which is an important measure of a baby's well-being. Amniotic fluid also keeps the umbilical cord from being compressed between the baby and the uterine wall.

Newron (SIX: NWRN) is a Biopharmaceutical company focused on the development of novel therapies for patients with diseases of the Central Nervous System (CNS) and pain. The Company is headquartered in Bresso near Milan, Italy. (MAA) for safinamide for the treatment of Parkinson's disease to the European Medicines Agency (EMA) in Decem ber 2013, Newron is working to complete the global filing of the compound, together with its part- Ners.

Milan, Italy, May 12, 2014 - Newron Pharmaceuticals SpA (Newron), a research and development company focused on novel CNS and pain therapies, and its partner Zambon SpA, an international pharmaceutical company strongly committed to CNS therapeutic area with a long experience in respiratory disease therapies, woman care and primary care , Inform markets that the safinamide NDA dossier has been finalized and undergoing quality control by an external vendor. The submission of the dossier to the US FDA is anticipated within the coming days.

Like this: